Prevalence and Risk Factors for Hepatitis C Virus, Hepatitis B Virus, and Human Immunodeficiency Virus in Transfused Children in Kinshasa

被引:6
|
作者
Katabuka, M. [1 ]
Mafuta, M. E. [2 ]
Ngoma, A. M. [3 ,6 ]
Beya, P. Mutombo [4 ]
Yuma, S. [5 ]
Aketi, L. [1 ]
Kayembe, K. P. [2 ]
Gini, J. R. [1 ]
机构
[1] Univ Kinshasa, Sch Med, Dept Pediat, Kinshasa, Japan
[2] Univ Kinshasa, Sch Med, Sch Publ Hlth, Kinshasa, Japan
[3] Fukushima Med Univ, Sch Med, Dept Blood Transfus & Transplantat Immunol, Fukushima 9601295, Japan
[4] Shimane Univ, Dept Environm & Prevent Med, Matsue, Shimane, Japan
[5] Blood Transfus Natl Program, Fukushima, Japan
[6] Fukushima Med Univ, Sch Med, Dept Transfus Med & Transplantat Immunol, Fukushima 9601295, Japan
关键词
Hepatitis C virus; Human immunodeficiency virus; Hepatitis B virus; Transfusion; Children; SICKLE-CELL-ANEMIA; BLOOD-TRANSFUSION; SAFETY; AMERICA; KENYA;
D O I
10.1007/s12098-012-0899-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To determine seroprevalence of hepatitis C virus (HCV), human immunodeficiency virus (HIV), and hepatitis B virus (HBV) and associated factors among transfused children. A multicenter cross-sectional study of transfused children aged between 18 mo and 13 y old was conducted in 4 hospitals in Kinshasa. Blood samples were collected for the detection of Hepatitis B surface antigen (HBsAg) and antibodies to HCV, HIV 1and 2. A total of 177 (47.7 %) boys and 194 (52.3 %) girls participated in the study. The median age was 59.5 mo (Interquartile range IQR = 60.6). The prevalence rates of HCV, HBV, and HIV infection were 13.5 %, 1.6 %, and 1.3 %, respectively. Frequency of transfusion events were significantly associated with HCV (p < 0.001) and HIV (p < 0.05) infections. HCV infection was by far more frequently identified than HBV and HIV infections among Congolese transfused children. Frequency of transfusion events was the only significant risk factor associated with HCV and HIV infections but not for HBV.
引用
收藏
页码:659 / 662
页数:4
相关论文
共 50 条
  • [31] Hepatitis C and human immunodeficiency virus coinfections
    Dodig, M
    Tavill, AS
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (05) : 367 - 374
  • [32] History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin
    Stark, K
    Bienzle, U
    Vonk, R
    Guggenmoos-Holzmann, I
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1997, 26 (06) : 1359 - 1366
  • [33] Intrafamilial transmission of hepatitis C virus in human immunodeficiency virus and hepatitis C virus co-infected patients
    Huët, C
    Dabis, F
    Saillour, F
    Trimoulet, P
    Morlat, P
    Rispal, P
    Dupon, M
    de la Taille, C
    Partisani, M
    Bertrand, M
    Ragnaud, JM
    Couzigou, P
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2000, 24 (6-7): : 611 - 617
  • [34] Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients
    Yan, Y. X.
    Gao, Y. Q.
    Sun, X.
    Wang, W.
    Huang, X. J.
    Zhang, T.
    Li, M.
    Zang, C. P.
    Li, Z. C.
    Wu, H.
    EPIDEMIOLOGY AND INFECTION, 2011, 139 (03) : 354 - 360
  • [35] Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection
    Crobu, Maria Grazia
    Ravanini, Paolo
    Impaloni, Clotilde
    Martello, Claudia
    Bargiacchi, Olivia
    Di Domenico, Christian
    Faolotto, Giulia
    Macaluso, Paola
    Mercandino, Alessio
    Riggi, Miriam
    Quaglia, Vittorio
    Andreoni, Stefano
    Pirisi, Mario
    Smirne, Carlo
    VIRUSES-BASEL, 2024, 16 (06):
  • [36] Prevalence of Co-infection of Hepatitis B Virus and Hepatitis C Virus among Human Immunodeficiency Virus Patients on Antiretroviral Therapy at A Tertiary Care Centre, Eluru, Andhra Pradesh, India
    Manjula, V.
    Krishnaveni, A.
    Viswabharathi, N.
    Jayalakshmi, L.
    Sasidhar, M.
    Jyothirmai, M.
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2024, 18 (04) : 2328 - 2335
  • [37] Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
    Kanada, Aimi
    Takehara, Tetsuo
    Ohkawa, Kazuyoshi
    Kato, Michio
    Tatsumi, Tomohide
    Miyagi, Takuya
    Sakamori, Ryotaro
    Yamaguchi, Shinjiro
    Uemura, Akio
    Kohga, Keisuke
    Sasakawa, Akira
    Hikita, Hayato
    Kawamura, Kiyomi
    Kanto, Tatsuya
    Hiramatsu, Naoki
    Hayashi, Norio
    HEPATOLOGY RESEARCH, 2008, 38 (06) : 622 - 628
  • [38] Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers
    Javadi, Abbasali
    Ataei, Behrooz
    Kassaian, Nazila
    Nokhodian, Zary
    Yaran, Majid
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 : S17 - S21
  • [39] Prevalence of human immunodeficiency virus/hepatitis C virus co-infection in Brazil and associated factors: a review
    Kuehlkamp, Valdete Meurer
    Schuelter-Trevisol, Fabiana
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (04) : 455 - 463
  • [40] Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: Evaluation of two chemiluminescent immunoassay systems
    Sommese, Linda
    Sabia, Chiara
    Paolillo, Rossella
    Parente, Delia
    Capuano, Maria
    Iannone, Carmela
    Cavalca, Francesco
    Schiano, Concetta
    Vasco, Maria
    De Pascale, Maria Rosaria
    Casamassimi, Amelia
    Napoli, Claudio
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2014, 46 (09) : 660 - 664